Anti-Complement C4 Nanobody (VHH), Recombinant, Purified

Anti-Complement C4 Nanobody (VHH), Recombinant, Purified

Catalog #: EG-NB-C401
$425.00
View Cart
3D Structure — Nanobody–Epitope Complex
Loading 3D structure…
anti-Complement C4 nanobody complex
PDB 7B2M
nanobody (VHH)   antigen   epitope (24)
Drag to rotate · scroll to zoom

Interactive model of the VHH bound to its structural epitope on Complement C4 (from experimental complex PDB 7B2M). Nanobody in blue, epitope contact residues in red. For research visualization.

Product Description
Product NameAnti-Complement C4 Nanobody (VHH), Recombinant, Purified
DescriptionA purified, engineered VHH nanobody against human complement C4 for complement-pathway and autoimmune-disease research.
Target / SpecificityHuman complement component C4 (alpha chain)
SequenceThis nanobody is an engineered variant based on PDB 7B2M, with higher affinity and stability than the original published sequence.
FormatPurified recombinant single-domain antibody (VHH / nanobody), carrier-free
Tag & ExpressionC-terminal 6×His tag; secreted from HEK293 cells and purified by one-step IMAC from the culture medium.
Molecular Weight~14 kDa (single VHH domain + His6; ~1/10 the size of a conventional IgG)
Purity>90% by SDS-PAGE
Quantity100 µg
FormulationPBS with 50% glycerol (carrier-free); 0.02% sodium azide
ApplicationsELISA, WB, IF, complement-pathway and autoimmune research
Structural EpitopeEpitope mapped from the experimental VHH–antigen complex (PDB 7B2M); 24 antigen contact residues within 5 Å. An interactive 3D complex model is shown on this page.
StorageStore at -20°C; avoid repeated freeze-thaw. Stable 1 year.
AdvantagesNanobodies are the smallest functional antibody fragments: exceptional thermal and chemical stability, single-domain, high-yield recombinant production, and access to cryptic epitopes and dense tissue that conventional antibodies cannot reach.
Product Documents
DatasheetEG-NB-C401 Product Datasheet
Download PDF
Related Products